A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers
NCT03207425
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
29
Enrollment
INDUSTRY
Sponsor class
Conditions
NASH
Interventions
DRUG:
EDP 305
Sponsor
Enanta Pharmaceuticals, Inc